Application 210978
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOBAZAM | CLOBAZAM | SUSPENSION;ORAL | 2.5MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-4210 | Clobazam | clobazam | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4227 | Clobazam | clobazam | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4227 | Clobazam | clobazam | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |